Dr. Haten Soliman, M.D.
Claim this profileArea of expertise
Breast Cancer
Haten Soliman, M.D. has run 1 trial for Breast Cancer. Some of their research focus areas include:
More about Haten Soliman, M.D.
Clinical Trial Related
7 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Haten Soliman, M.D. has experience with
- Curative Surgery
- DC1
- Neoadjuvant Chemotherapy
Breakdown of trials Haten Soliman, M.D. has run
Breast Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Haten Soliman, M.D. specialize in?
Haten Soliman, M.D. focuses on Breast Cancer and other conditions. In particular, much of their work with Breast Cancer has involved Stage III patients, or patients who are HER2 positive.
Is Haten Soliman, M.D. currently recruiting for clinical trials?
No, Haten Soliman, M.D. is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Haten Soliman, M.D. has studied deeply?
Yes, Haten Soliman, M.D. has studied treatments such as Curative Surgery, DC1, Neoadjuvant Chemotherapy.
What is the best way to schedule an appointment with Haten Soliman, M.D.?
Apply for one of the trials that Haten Soliman, M.D. is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.